Vivo Capital, LLC Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$2.8T
Holdings
63
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (63 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | TILInstil Bio Inc | 12,486,787 | $313.2B | 11.01% | |
| 2 | ALXOALX Oncology Holdings Inc | 4,220,048 | $311.2B | 10.94% | |
| 3 | AMRSEURAmyris, Inc | 13,161,847 | $251.4B | 8.84% | |
| 4 | ASNDAscendis Pharma A/S | 1,664,242 | $214.5B | 7.54% | |
| 5 | —New Frontier Health Corp | 14,300,000 | $161.6B | 5.68% | |
| 6 | HRMYHarmony Biosciences Holdings Inc | 4,534,341 | $149.8B | 5.27% | |
| 7 | —Genetron Holdings Ltd | 6,339,860 | $136.1B | 4.78% | |
| 8 | BOLT1EURBolt Therapeutics Inc | 3,871,291 | $127.4B | 4.48% | |
| 9 | TARSTarsus Pharmaceuticals Inc | 3,245,035 | $104.6B | 3.68% | |
| 10 | ALGSAligos Therapeutics Inc | 3,547,030 | $80.7B | 2.83% | |
| 11 | LEGNLegend Biotech Corp Sponsored | 2,755,007 | $80.0B | 2.81% | |
| 12 | EPIEUREssa Pharma Inc | 2,068,907 | $60.1B | 2.11% | |
| 13 | TERNTerns Pharmaceuticals Inc | 2,675,133 | $58.9B | 2.07% | |
| 14 | KALVKalVista Pharmaceuticals Inc. | 1,863,296 | $47.9B | 1.68% | |
| 15 | ACRSAclaris Therapeutics, Inc. | 1,647,214 | $41.5B | 1.46% | |
| 16 | OLMAOlema Pharmaceuticals Inc | 1,238,575 | $41.1B | 1.44% | |
| 17 | SVASinovac Biotech Ltd. | 5,900,000 | $38.2B | 1.34% | |
| 18 | OPHTEURIveric Bio Inc | 5,966,527 | $36.9B | 1.30% | |
| 19 | CRNXCrinetics Pharmaceuticals Inc | 2,214,138 | $33.8B | 1.19% | |
| 20 | —Sierra Oncology, Inc | 1,917,074 | $33.0B | 1.16% | |
| 21 | NVV1Novavax Inc | 157,487 | $28.6B | 1.00% | |
| 22 | TCE2Celldex Therapeutics Inc | 1,291,875 | $26.6B | 0.94% | |
| 23 | AVDLAvadel Pharmaceuticals PLC | 2,937,093 | $26.6B | 0.93% | |
| 24 | VRNAVerona Pharma PLC ADR | 3,048,507 | $25.5B | 0.90% | |
| 25 | PASGPassage Bio Inc | 1,413,508 | $24.7B | 0.87% | |
| 26 | GRCLGracell Biotechnologies Inc | 1,522,994 | $23.5B | 0.82% | |
| 27 | ZLABZai Lab Ltd ADR | 175,000 | $23.4B | 0.82% | |
| 28 | —Kadmon Holdings Inc | 5,817,459 | $22.6B | 0.80% | |
| 29 | ARQTArcutis Biotherapeutics Inc | 744,370 | $21.5B | 0.76% | |
| 30 | AKROAkero Therapeutics Inc | 673,280 | $19.5B | 0.69% | |
| 31 | 290AChinook Therapeutics Inc | 1,206,266 | $18.7B | 0.66% | |
| 32 | —Curis Inc | 1,553,500 | $17.6B | 0.62% | |
| 33 | NKTXNkarta Inc | 512,225 | $16.9B | 0.59% | |
| 34 | CYTKCytokinetics Inc | 700,000 | $16.3B | 0.57% | |
| 35 | DSGNDesign Therapeutics | 530,991 | $15.9B | 0.56% | |
| 36 | CLDNEUREiger BioPharmaceuticals Inc | 1,791,257 | $15.9B | 0.56% | |
| 37 | KURAKura Oncology Inc | 525,262 | $14.8B | 0.52% | |
| 38 | MREOMereo Biopharma Group PLC | 4,220,938 | $14.2B | 0.50% | |
| 39 | LRMRLarimar Therapeutics Inc | 799,662 | $11.7B | 0.41% | |
| 40 | CGEMCullinan Management Inc | 250,000 | $10.4B | 0.37% | |
| 41 | ORTXUSDOrchard Therapeutics plc | 1,325,736 | $9.6B | 0.34% | |
| 42 | —Aslan Pharmaceuticals Ltd | 2,840,909 | $9.5B | 0.33% | |
| 43 | ARWRArrowhead Pharmaceuticals Inc | 137,411 | $9.1B | 0.32% | |
| 44 | —Zymeworks Inc | 286,064 | $9.0B | 0.32% | |
| 45 | DYNDyne Therapeutics Inc | 577,642 | $9.0B | 0.32% | |
| 46 | CDXSCodexis, Inc | 388,144 | $8.9B | 0.31% | |
| 47 | —Calliditas Therapeutics ADR | 311,030 | $8.6B | 0.30% | |
| 48 | IMVTImmunovant Inc | 532,847 | $8.5B | 0.30% | |
| 49 | FIXXEURHomology Medicines, Inc. | 853,143 | $8.0B | 0.28% | |
| 50 | —Satsuma Pharmaceuticals Inc | 1,232,394 | $7.3B | 0.26% | |
| 51 | SNDXSyndax Pharmaceuticals Inc | 320,000 | $7.2B | 0.25% | |
| 52 | AUPHAurinia Pharmaceuticals Inc. | 500,732 | $6.5B | 0.23% | |
| 53 | KALAKala Pharmaceuticals, Inc. | 786,883 | $5.3B | 0.19% | |
| 54 | ATRCAtricure Inc | 64,573 | $4.2B | 0.15% | |
| 55 | MRUSMerus NV | 175,000 | $3.7B | 0.13% | |
| 56 | —Constellation Pharmaceutical | 140,298 | $3.3B | 0.12% | |
| 57 | TXG10X Genomics Inc | 14,798 | $2.7B | 0.09% | |
| 58 | —Zogenix Inc | 105,000 | $2.0B | 0.07% | |
| 59 | —VYNE Therapeutics Inc | 234,877 | $1.6B | 0.06% | |
| 60 | 1K0IGM Biosciences Inc | 20,000 | $1.5B | 0.05% | |
| 61 | DTILPrecision Biosciences Inc | 140,255 | $1.5B | 0.05% | |
| 62 | 1T7Tricida, Inc. | 174,763 | $924.0M | 0.03% | |
| 63 | —Metacrine Inc | 146,426 | $908.0M | 0.03% |